Conference Coverage

Survey: Reproductive counseling is often MIA in IBD


 

REPORTING FROM THE CROHN’S & COLITIS CONGRESS

– Inflammatory bowel disease (IBD) can disrupt both fertility and pregnancy, especially if it’s not fully controlled, and there’s a risk that the condition can be passed onto an unborn child. Still a new study suggests many patients with IBD don’t receive appropriate reproductive counseling.

Dr. Sarah Streett of Stanford (Calif.) University

Dr. Sarah Streett

Nearly two-thirds of 100 patients surveyed at a single center reported that no physician had talked to them about reproductive topics, and some said they’d considered not having children because of the condition. “Really fundamental subjects have not made their way into the interactions between patients and their care teams,” coauthor and gastroenterologist Sarah Streett, MD, AGAF, of Stanford (Calif.) University, said in an interview before the study was presented at the annual congress of the Crohn’s & Colitis Foundation and the American Gastroenterological Association.

IBD can lower fertility in both sexes and boost complications in pregnancy. “The good news is that almost all the medications used for IBD appear safe,” Dr. Streett said. “In fact, the safety risks for the baby and the pregnancy revolve around not having IBD under good control.”

Unfortunately, she said, misinformation is common. “Patients who become pregnant or are trying to become pregnant, and are worried about potential harm to the baby, will stop the medications due to incorrect information. Or they’ll be told by their health care team to stop their medications.”

Dr. Streett and study lead author Aarti Rao, MD, a gastroenterology fellow at Stanford, launched their study of IBD clinic patients to gain more understanding about patient knowledge. “We know from research already published that those with IBD have a lot of concerns about starting families and don’t have a lot of information to base their decision making on,” Dr. Streett said. “We wanted to evaluate that in our population and see how much people knew and what the need was.”

Dr. Aarti Rao of Stanford (Calif.) University

Dr. Aarti Rao

In 2018 and 2019, Dr. Streett and Dr. Rao gave an anonymous, validated 17-question survey to patients aged 18-45 with IBD. One hundred patients responded (median age = 30, 54% female, 59% white, 66% with incomes over $100,000, 52% with ulcerative colitis, 21% with prior IBD surgery, 71% with prior IBD hospitalization).

Just over a third – 35% – of the patients said they’d been counseled about reproductive health by a physician. This finding reflects findings in previous research, said Dr. Rao, who spoke in an interview.

Just 15% of those who’d undergone IBD surgery reported getting guidance about the effects of surgery on fertility.

More than a third (35%) of women and 15% of men said they’d considered not having children because of their IBD. In fact, “most potential dads and moms have the chance to do very well,” Dr. Streett said.

Without reproductive counseling, she added, parents won’t know about the risks of passing on IBD. According to Dr. Rao, there’s an estimated less than 5% chance that IBD will be passed on to children if one parent has the condition; the risk is much higher if both parents have it.

Going forward, “there’s a really urgent need for proactive counseling on the part of gastroenterologists and health care teams to give people of childbearing age the right information so they can be informed to make the best decisions,” Dr. Streett said.

The study was funded by a philanthropic grant. The study authors report no relevant disclosures.

Recommended Reading

MDedge Daily News: Fewer smokes mean fewer strokes
MDedge ObGyn
MDedge Daily News: How to handle opioid constipation
MDedge ObGyn
MDedge Daily News: Keeping patients summer safe
MDedge ObGyn
ACS: Screen for colon cancer at 45
MDedge ObGyn
Tumor analysis: Test all MSI-high patients for Lynch Syndrome
MDedge ObGyn
Commentary: Composite risk, not age, is key for timing first colorectal cancer screening
MDedge ObGyn
Colonoscopy: Should 45 be the new 50?
MDedge ObGyn
Aspirin cuts risk of ovarian and liver cancer
MDedge ObGyn
Probiotics and pediatric gastroenteritis
MDedge ObGyn
FDA approves third trastuzumab biosimilar
MDedge ObGyn